Iovance Biotherapeutics was Granted Fast Track Designation for LN-145 for Cervical Cancer
Go back to Iovance Biotherapeutics was Granted Fast Track Designation for LN-145 for Cervical Cancer| (NASDAQ: IOVA) | Delayed: 4.44 +0.38 (9.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.06 | 52 Week High | $ | |||
| Open | $4.00 | 52 Week Low | $ | |||
| Day High | $4.52 | P/E | N/A | |||
| Day Low | $3.99 | EPS | $ | |||
| Volume | 17,963,568 | |||||
